1. Home
  2. RMD vs ABEV Comparison

RMD vs ABEV Comparison

Compare RMD & ABEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • ABEV
  • Stock Information
  • Founded
  • RMD 1989
  • ABEV 1885
  • Country
  • RMD United States
  • ABEV Brazil
  • Employees
  • RMD N/A
  • ABEV N/A
  • Industry
  • RMD Medical/Dental Instruments
  • ABEV Beverages (Production/Distribution)
  • Sector
  • RMD Health Care
  • ABEV Consumer Staples
  • Exchange
  • RMD Nasdaq
  • ABEV Nasdaq
  • Market Cap
  • RMD 36.5B
  • ABEV 36.2B
  • IPO Year
  • RMD 1995
  • ABEV N/A
  • Fundamental
  • Price
  • RMD $241.61
  • ABEV $2.15
  • Analyst Decision
  • RMD Buy
  • ABEV Hold
  • Analyst Count
  • RMD 11
  • ABEV 2
  • Target Price
  • RMD $227.63
  • ABEV $2.68
  • AVG Volume (30 Days)
  • RMD 1.2M
  • ABEV 20.2M
  • Earning Date
  • RMD 10-24-2024
  • ABEV 10-31-2024
  • Dividend Yield
  • RMD 0.88%
  • ABEV 6.78%
  • EPS Growth
  • RMD 22.60
  • ABEV N/A
  • EPS
  • RMD 7.54
  • ABEV 0.16
  • Revenue
  • RMD $4,807,485,000.00
  • ABEV $15,133,784,839.00
  • Revenue This Year
  • RMD $10.09
  • ABEV $11.37
  • Revenue Next Year
  • RMD $7.15
  • ABEV $5.64
  • P/E Ratio
  • RMD $32.04
  • ABEV $13.24
  • Revenue Growth
  • RMD 9.88
  • ABEV N/A
  • 52 Week Low
  • RMD $151.95
  • ABEV $2.01
  • 52 Week High
  • RMD $260.49
  • ABEV $3.00
  • Technical
  • Relative Strength Index (RSI)
  • RMD 50.22
  • ABEV 36.61
  • Support Level
  • RMD $231.17
  • ABEV $2.16
  • Resistance Level
  • RMD $242.47
  • ABEV $2.23
  • Average True Range (ATR)
  • RMD 5.37
  • ABEV 0.05
  • MACD
  • RMD -0.60
  • ABEV -0.00
  • Stochastic Oscillator
  • RMD 43.89
  • ABEV 14.09

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About ABEV Ambev S.A.

Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving Interbrew (now AB InBev) a controlling interest of 61.8% as at the end of 2023.

Share on Social Networks: